$4.41
-0.07-1.56%
At close: -
$4.37
-0.04-0.91%
After Hours: Jan 17, 7:59 PM EDT
Humacyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Humacyte using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-08 | $-0.33 | $-0.25 | -32.0 % |
Q2 | 2024-08-13 | $-0.27 | $-0.24 | -12.5 % |
Q1 | 2024-05-10 | $-0.29 | $-0.22 | -31.8 % |
Q4 | 2024-03-22 | $-0.24 | $-0.24 | 0.00 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2024-05-10 | $0 | $20.00K | -100.0 % |
Q4 | 2024-03-22 | $0 | $60.00K | -100.0 % |
Q3 | 2023-11-09 | $0 | $70.00K | -100.0 % |
Q2 | 2023-08-14 | $0 | $70.00K | -100.0 % |
Humacyte (HUMA) is scheduled to report earnings on March 21, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $-0.33, which missed the estimate of $-0.25.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.